Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Covalon Technologies (TSE:COV)
:COV
Holding TSE:COV?
Track your performance easily
COV Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.97 - C$4.30
Previous CloseN/A
Volume11.70K
Average Volume (3M)35.02K
Market Cap
C$90.96M
Enterprise ValueC$75.94M
Total Cash (Recent Filing)$4.16M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)29.9
Beta0.37
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding27,398,077
10 Day Avg. Volume71,973
30 Day Avg. Volume35,023
Standard Deviation0.18
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.92
Price to Cash Flow (P/CF)10.70
P/FCF Ratio10.70
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue2.44
Enterprise Value/Gross Profit4.01
Enterprise Value/Ebitda20.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Covalon Technologies News
PremiumCompany Announcements
Covalon Technologies Reports Robust Fiscal 2024 Growth and Profitability
PremiumCompany Announcements
Covalon Technologies to Announce Year-End Financial Results
PremiumCompany Announcements
Covalon Technologies Highlights Innovations at Magnet Conference
PremiumCompany Announcements
Covalon Showcases Innovation at Vascular Access MeetingPremiumCompany Announcements
Covalon Technologies Strengthens Cash Position
PremiumCompany Announcements
Covalon Showcases Pediatric Vascular Innovations at APHONPremiumCompany Announcements
Covalon Technologies Soars with Q3 Financial Growth
PremiumCompany Announcements
Covalon Technologies to Unveil Q3 Financial ResultsOptions Prices
Currently, No data available
---
Ownership Overview
COV FAQ
What was Covalon Technologies’s price range in the past 12 months?
Covalon Technologies lowest stock price was C$0.97 and its highest was C$4.30 in the past 12 months.
What is Covalon Technologies’s market cap?
Covalon Technologies’s market cap is C$90.96M.
When is Covalon Technologies’s upcoming earnings report date?
Covalon Technologies’s upcoming earnings report date is Mar 04, 2025 which is in 44 days.
How were Covalon Technologies’s earnings last quarter?
Covalon Technologies released its earnings results on Jan 07, 2025. The company reported C$0.02 earnings per share for the quarter, beating the consensus estimate of -C$0.03 by C$0.05.
Is Covalon Technologies overvalued?
According to Wall Street analysts Covalon Technologies’s price is currently Overvalued.
Does Covalon Technologies pay dividends?
Covalon Technologies does not currently pay dividends.
What is Covalon Technologies’s EPS estimate?
Covalon Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Covalon Technologies have?
Covalon Technologies has 27,398,077 shares outstanding.
What happened to Covalon Technologies’s price movement after its last earnings report?
Covalon Technologies reported an EPS of C$0.02 in its last earnings report, beating expectations of -C$0.03. Following the earnings report the stock price went down -8.357%.
Which hedge fund is a major shareholder of Covalon Technologies?
Currently, no hedge funds are holding shares in TSE:COV
---
Covalon Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
157.95%
12-Months-Change
Fundamentals
Return on Equity
11.53%
Trailing 12-Months
Asset Growth
27.73%
Trailing 12-Months
Company Description
Covalon Technologies
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts and sales.
---
Technical Analysis
Constellation Software
―
VIQ Solutions
―
ProMIS Neurosciences
―
Microbix Biosystms
―
Resverlogix
―
---